Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263756 · ClinicalTrials.gov registry record
Autism Spectrum Disorders (ASD) Driving Study
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 10
- Enrollment target
NCT01263756: Completed study, sponsored by Massachusetts General Hospital.
NCT01263756 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01263756 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The proposed pilot study will begin to assess whether driving impairments are included in the functional deficits associated with Autism Spectrum Disorders (ASDs). This will be completed by obtaining data on velocity, collision risk, and visual attention of subjects with ASDs who drive in a simulator. The study includes 2-3 visits for the screening period (approximately 6 hours of assessments) and one driving simulation visit (approximately 2.5 hours). The investigators expect to enroll 20 adolescents and adults (ages 16-50, inclusive) who have been identified as having an ASD from a prior diagnosis or participation in community conferences for individuals with ASDs.
Primary Outcome
Data will be obtained on velocity, collision risk, and visual attention of subjects with ASDs who drive in the driving simulator at the Massachusetts Institute of Technology (MIT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-03 |
What the finished NCT01263756 record still lists
NCT01263756 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01263756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01263756 about?
NCT01263756 is a clinical study titled "Autism Spectrum Disorders (ASD) Driving Study". The proposed pilot study will begin to assess whether driving impairments are included in the functional deficits associated with Autism Spectrum Disorders (ASDs). This will be completed by obtaining data on velocity, collision risk, and visual attention of subjects with ASDs who drive in a simulato...
What is the current status of trial NCT01263756?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2010-03. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT01263756?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia